Attached files
Exhibit 24
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company's Annual Report on Form 10-K for the
fiscal year ended December 31, 2009 and all amendments, exhibits and supplements thereto.
Date: February 19, 2010 /s/
Thomas W. Hofmann
Thomas
W. Hofmann
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company's Annual Report on Form 10-K for the
fiscal year ended December 31, 2009 and all amendments, exhibits and supplements thereto.
Date: February 19, 2010 /s/
L. Robert Johnson
L.
Robert Johnson
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as her attorneys-in-fact to sign on her behalf and in her capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company's Annual Report on Form 10-K for the
fiscal year ended December 31, 2009 and all amendments, exhibits and supplements thereto.
Date: February 19, 2010 /s/
Paula A. Johnson
Paula
A. Johnson
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company's Annual Report on Form 10-K for the
fiscal year ended December 31, 2009 and all amendments, exhibits and supplements thereto.
Date: February 19, 2010 /s/
John P. Neafsey
John
P. Neafsey
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company's Annual Report on Form 10-K for the
fiscal year ended December 31, 2009 and all amendments, exhibits and supplements thereto.
Date: February 19, 2010 /s/
John H. Weiland
John
H. Weiland
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company's Annual Report on Form 10-K for the
fiscal year ended December 31, 2009 and all amendments, exhibits and supplements thereto.
Date: February 19, 2010 /s/
Anthony Welters
Anthony
Welters
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company's Annual Report on Form 10-K for the
fiscal year ended December 31, 2009 and all amendments, exhibits and supplements thereto.
Date: February 19, 2010 /s/
Geoffrey F. Worden
Geoffrey
F. Worden
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company's Annual Report on Form 10-K for the
fiscal year ended December 31, 2009 and all amendments, exhibits and supplements thereto.
Date: February 19, 2010 /s/
Robert C. Young, M.D.
Robert
C. Young, M.D.
POWER OF ATTORNEY
The undersigned hereby authorizes and appoints Donald E. Morel, Jr. and John R. Gailey III, and each of them, as his attorneys-in-fact to sign on his behalf and in his capacity as a director of West Pharmaceutical Services, Inc., and to file, the Company's Annual Report on Form 10-K for the
fiscal year ended December 31, 2009 and all amendments, exhibits and supplements thereto.
Date: February 19, 2010 /s/
Patrick J. Zenner
Patrick J. Zenner